Frontiers in Immunology (Nov 2016)

The Ly49E receptor inhibits the immune control of acute Trypanosoma cruzi infection

  • Jessica Filtjens,
  • Nicolas Coltel,
  • Sabrina Cencig,
  • Sylvie Taveirne,
  • Els Van Ammel,
  • Aline Van Acker,
  • Tessa Kerre,
  • Patrick Matthys,
  • Tom Taghon,
  • Bart Vandekerckhove,
  • Yves Carlier,
  • Carine Truyens,
  • Georges Leclercq

DOI
https://doi.org/10.3389/fimmu.2016.00472
Journal volume & issue
Vol. 7

Abstract

Read online

The protozoan parasite Trypanosoma cruzi (T. cruzi) circulates in the blood upon infection and invades a variety of cells. Parasites intensively multiply during the acute phase of infection and persist lifelong at low levels in tissues and blood during the chronic phase. Natural killer (NK) and NKT cells play an important role in the immune control of T. cruzi infection, mainly by releasing the cytokine IFN-γ that activates the microbicidal action of macrophages and other cells and shapes a protective type 1 immune response. The mechanisms by which immune cells are regulated to produce IFN-γ during T. cruzi infection are still incompletely understood. Here, we show that urokinase plasminogen activator (uPA) is induced early upon T. cruzi infection, and remains elevated until day 20 post inoculation. We previously demonstrated that the inhibitory receptor Ly49E, which is expressed, among others, on NK and NKT cells, is triggered by uPA. Therefore, we compared wild type (WT) to Ly49E knockout (KO) mice for their control of experimental T. cruzi infection. Our results show that young, i.e. 4- and 6-week-old, Ly49E KO mice control the infection better than WT mice, indicated by a lower parasite load and less cachexia. The beneficial effect of Ly49E depletion is more obvious in 4-week-old male than in female mice and weakens in 8-week-old mice. In young mice, the lower T. cruzi parasitemia in Ly49E KO mice is paralleled by higher IFN-γ production compared to their WT controls. Our data indicate that Ly49E receptor expression inhibits the immune control of T. cruzi infection. This is the first demonstration that the inhibitory Ly49E receptor can interfere with the immune response to a pathogen in vivo.

Keywords